Prot #C34001: An Open-Label, Dose Escalation, Phase 1, First-in-Human Study of TAK-659 in Adult Patients with Advanced Solid Tumor and Lymphoma Malignancies

Project: Research project

Project Details

StatusActive
Effective start/end date1/23/141/23/23

Funding

  • Millennium Pharmaceuticals, Inc (Prot #C34001)